Beruflich Dokumente
Kultur Dokumente
MODULE 2
Cleanroom Standards
The first standard written for cleanroom was published by the American Air force on March 1961. It was known as Technical Manual (T.O) 00-25-203.
Cleanroom Standards
The first Federal standard 209 was produced in the year 1963. Conventional and unidirectional cleanrooms were discussed. Measurement of particles of 0.5 m by means of optical particle counters was defined. Why 0.5 m? Art of achievable At that time this was the smallest size that was easily measured by optical particle counters.
The condition where the installation is functioning In the specified manner, with specified number of personnel present and working in the manner Agreed upon.
EU GGMP
European Union Guide to Good Manufacturing Practice. The most recent pharmaceutical standard used In Europe came into operation on January 1997. It was revised in 2003.
For the manufacture of sterile medicinal products Four grades of airborne cleanliness are given.
EU GGMP
EU GGMP
The maximum permitted number of particles in the At rest condition. EU GGMP Grade A & B FS 209E 100 ISO 5
Grade C Grade D
10000 100000
7 8
EU GGMP
Examples of cleanroom conditions required for Different operations. Terminally Sterilized Products Grade A Filling of products, when unusually at risk.
EU GGMP
Examples of cleanroom conditions required for Different operations. Aseptic Preparations Grade A Aseptic preparation and filling. Grade C Preparation of solutions to be filtered. Grade D Handling of components after washing.
EU GGMP
Microbiological monitoring also required to demonstrate the microbiological cleanliness of the cleanroom during production.
EU GGMP
These are average values Individual settle plates may be exposed for less than 4 hours. Appropriate alert and action limits should be set for the results of particulate and microbiological monitoring. If these limits are exceeded, operating procedures should prescribe corrective action.
US FDA
Guideline on Sterile Drug Products Produced by Aseptic Processing. This document was published in 1987 by USFDA. Revised on September 2004
US FDA
Critical Area:one in which the sterilized dosage form, containers, and closures are exposed to the environment. Activities that are conducted in this area include manipulations of these sterilized materials/product prior to and during filling/closing operations.
Air should be supplied a the point of use as HEPA filtered laminar air flow. Velocity 90 20 feet per minute Not more than 1 colony forming unit per 10 cubic feet Should have positive pressure differential relative to adjacent less clean areas A pressure differential of 0.05 inch of water is acceptable.
US FDA
Controlled Area:An area in which it is important to control the environment, is the area where un-sterilized product, in-process materials, and container/ closures are prepared. This includes areas where components are compounded, and where components, in-process materials, drug products and drug product contact surfaces of equipment, containers, and closures, after final rinse of such surfaces, are exposed to the plant environment.
When doors are open, outward airflow should be sufficient to minimize ingress of contamination.
US FDA
WHO 2002
Schedule M
Class
<= ISO 5 >ISO 5
Air Pressure Difference All Classes 12 Months Airflow All Classes 12 months
Test Parameter
Class
END OF MODULE - 2